LAB vs VMC · rev $174.4M vs P/E 35, rev $7.42B
Standard Biotools Inc (LAB) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
LAB currently screens at market cap $317.1M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the LAB and VMC stock pages for the full models.
Not investment advice.